# Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer

> **NCT05854368** · NA · RECRUITING · sponsor: **Institut Pasteur** · enrollment: 2500 (estimated)

## Conditions studied

- Gastric Lesion
- Gastric Precancerous Condition
- Gastric Cancer

## Interventions

- **PROCEDURE:** Additional blood collection as part of a blood sampling performed during routine care or specific for the research if not part of routine care.
- **PROCEDURE:** Blood collection

## Key facts

- **NCT ID:** NCT05854368
- **Lead sponsor:** Institut Pasteur
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-03
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05854368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05854368, "Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05854368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*